Difference between revisions of "Danaparoid (Orgaran)"
Jump to navigation
Jump to search
(Created page with "==General information== Class/mechanism: Low molecular weight heparin ==History of changes in FDA indication== *6/26/2001: Initial FDA approval ==Also known as== *'''Brand n...") |
|||
(4 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
− | * | + | *2001-06-26: Initial approval |
==Also known as== | ==Also known as== | ||
Line 15: | Line 15: | ||
[[Category:Low molecular weight heparins]] | [[Category:Low molecular weight heparins]] | ||
− | [[Category:Venous thromboembolism ( | + | [[Category:Heparin-induced thrombocytopenia medications (historic)]] |
+ | [[Category:Venous thromboembolism medications (historic)]] | ||
[[Category:FDA approved in 2001]] | [[Category:FDA approved in 2001]] | ||
− | [[Category:Discontinued]] | + | [[Category:Discontinued drugs]] |
Latest revision as of 04:23, 5 June 2023
General information
Class/mechanism: Low molecular weight heparin
History of changes in FDA indication
- 2001-06-26: Initial approval
Also known as
- Brand name: Orgaran